logo

For the Inventor, By the Inventor

Conshohocken, PA, United States of America

Christina Di Marco

This inventor holds 10 USPTO granted patents and 1 EPO patent. Top assignees: Merck Sharp + Dohme Corp., Other. Active years: 2012-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christina Di Marco. Retrieved from https://idiyas.com/inventor/christina-di-marco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 80.0

 

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 34(Granted Patents)


Location History:

  • Conshohocken, PA (US) (2012 - 2015)
  • Lafayette Hill, PA (US) (2017)

Company Filing History:

goldMedal9 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal1 out of 834,570 
Other
 patents

Years Active: 2012-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 9714243 - 4-pyridinonetriazine derivatives as HIV integrase inhibitors (2017-07-25),
2. 9029364 - 2,5-disubstituted thiomorpholine orexin receptor antagonists (2015-05-12),
3. 8883810 - Aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators (2014-11-11),
4. 8557832 - Aryl methyl benzoquinazolinine M1 receptor positive allosteric modulators (2013-10-15),
5. 8436016 - Fused heterocyclic M1 receptor positive allosteric modulators (2013-05-07),
6. 8426598 - N-heterocyclic M1 receptor positive allosteric modulators (2013-04-23),
7. 8293914 - 4-OXO,1-4-dihydroquinoline M1 receptor positive allosteric modulators (2012-10-23),
8. 8288409 - Quinolizidinone M1 receptor positive allosteric modulators (2012-10-16),
9. 8278453 - Quinolizidinone M1 receptor positive allosteric modulators (2012-10-02),
10. 8173672 - Quinolizidinone M1 receptor positive allosteric modulators (2012-05-08),

Title: Christina Di Marco: Innovator in Pharmaceutical Chemistry

Introduction

Christina Di Marco is a prominent inventor based in Conshohocken, PA (US). She has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. Her work focuses on developing innovative compounds that address critical health issues.

Latest Patents

Among her latest patents is the invention of 4-pyridinonetriazine derivatives as HIV integrase inhibitors. This invention relates to specific derivatives and their pharmaceutically acceptable salts, which are designed to treat or prevent HIV infection. Another notable patent involves 2,5-disubstituted thiomorpholine orexin receptor antagonists. This invention targets neurological and psychiatric disorders by utilizing compounds that act as antagonists of orexin receptors.

Career Highlights

Christina has worked with Merck Sharp & Dohme Corporation, where she has contributed to various research projects and innovations. Her expertise in pharmaceutical chemistry has positioned her as a key player in the development of new therapeutic agents.

Collaborations

Throughout her career, Christina has collaborated with notable colleagues, including Scott D Kuduk and Ronald K Chang. These partnerships have enhanced her research and contributed to the advancement of her inventions.

Conclusion

Christina Di Marco's innovative work in pharmaceutical chemistry has led to significant advancements in the treatment of various health conditions. Her patents reflect her commitment to improving healthcare through scientific research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…